NASDAQ · Financial Statements
Orchard Therapeutics plc (ORTX) Financial Statements
$16.70
NASDAQ: ORTX
Market Cap $380.11M
Overview Financials Dividend Orchard Therapeutics plc most recently reported annual revenue of $7.0M, net profit of $-8.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $2.0M $3.0M $3.0M $0 $7.0M Operating Profit $-235.0M $-173.0M $-157.0M $-36.0M $-32.0M Net Profit $-230.0M $-163.0M $-152.0M $-36.0M $-8.0M EPS $-102.17 $-17.53 $-15.28 $-2.93 $-0.61 Op Margin -11321.3% -6879.1% -6049.3% -7539.3% -452.2%
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $366.0M $399.0M $281.0M $322.0M $219.0M Total Liabilities $55.0M $100.0M $103.0M $112.0M $121.0M Cash $336.0M $19.0M $55.0M $56.0M $68.0M Borrowings $0 $46.0M $58.0M $59.0M $58.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-98.0M $-166.0M $-126.0M $-125.0M $-76.0M Investing Cash Flow $-8.0M $-314.0M $145.0M $-35.0M $84.0M Financing Cash Flow $355.0M $157.0M $4.0M $158.0M $-1.0M Net Cash Flow $250.0M $-316.0M $36.0M $1.0M $12.0M Free Cash Flow $-102.0M $-170.0M $-139.0M $-128.0M $-83.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -45.77 FCF Yield -21.70% Quick Ratio 2.72 Interest Coverage -33.86 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock